Stop Calling It a Free Lunch: Why Biotech Spillovers Make Everyone Safer

Biotech knowledge spillovers cut global wait times for lifesaving therapies
Rich countries gain when diffusion is designed, priced, and measured—not blocked
Universities and funders should hard-wire reciprocity, open methods, and cross-border teams